Serial blood pressure measurements, left ventricular remodelling and cardiovascular outcomes

Magnus Nakrem Lyngbakken1,2, Brede Kvisvik1,3, Trygve Berge3,4

  • 1Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.

Insights

Serial blood pressure (BP) measurements, unlike individual ones, strongly correlate with left ventricular (LV) remodelling and predict cardiovascular events in healthy adults. These findings suggest serial BP monitoring may offer superior risk assessment for cardiovascular disease.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • Hypertension is a primary risk factor for cardiovascular disease (CVD).
  • The predictive value of serial blood pressure (BP) measurements versus individual measurements for subclinical left ventricular (LV) remodelling and cardiovascular events remains unclear.

Purpose of the Study:

  • To investigate the association between serial BP measurements and LV remodelling.
  • To determine if serial BP measurements better predict incident cardiovascular events compared to individual BP measurements.

Main Methods:

  • Assessed systolic BP, diastolic BP, and pulse pressure over time in 1333 women and 1211 men from the Akershus Cardiac Examination 1950 Study.
  • Defined serial BP as averaged BPs from consecutive visits, indexed to exposure time.
  • Examined associations with LV structure, function, volumes, and incident myocardial infarction, ischemic stroke, heart failure, and cardiovascular death.

Main Results:

  • Higher serial BP measurements were associated with increased indexed LV mass, with stronger associations than individual BP measurements.
  • Serial diastolic BP was inversely associated with LV systolic function; serial systolic BP correlated with higher LV volumes.
  • Both serial systolic and diastolic BPs were associated with increased incidence of clinical cardiovascular events.

Conclusions:

  • Serial BP indices show strong associations with LV remodelling and cardiovascular outcomes in healthy individuals.
  • Further prospective studies are needed to determine if serial BP indices are superior to individual measurements for guiding treatment decisions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
192
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
288
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31